Voloridge Investment Management »

Eyepoint Pharmaceuticals shares owned by Voloridge Investment Management

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Voloridge Investment Management from 13F filings

Historical chart of Voloridge Investment Management investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Voloridge Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Voloridge Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.3M 141k 23.11

More positions owned by Voloridge Investment Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Procter & Gamble Company (PG)
Bristol Myers Squibb (BMY)
O'reilly Automotive (ORLY)
AutoZone (AZO)
Snowflake Cl A (SNOW)
Lockheed Martin Corporation (LMT)
Automatic Data Processing (ADP)
Netflix (NFLX)
Hp (HPQ)
Block Cl A (SQ)
Exxon Mobil Corporation (XOM)
Jd.com Spon Adr Cl A (JD)

View all positions for Voloridge Investment Management

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Franklin Resources
T. Rowe Price Associates
Vanguard Group
Citadel Advisors
Perceptive Advisors
Millennium Management
Ikarian Capital
Deutsche Bank Aktiengesellschaft
Federated Investors
Fiera Capital Corporation
Laurion Capital Management
UBS Group
Goldman Sachs Group
Oracle Investment Management

View all funds holding Eyepoint Pharmaceuticals